차세대 시퀀싱 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 서비스별, 워크플로우별, 최종사용자별, 지역별 부문, 경쟁(2020-2030년)
Next Generation Sequencing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Workflow, By End User, By Region and Competition, 2020-2030F
상품코드:1763866
리서치사:TechSci Research
발행일:2025년 06월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 차세대 시퀀싱(NGS) 서비스 시장은 2024년에 59억 7,000만 달러로 평가되며, 예측 기간 중 CAGR 22.92%로 성장하며, 2030년에는 205억 9,000만 달러에 달할 것으로 예측됩니다.
이러한 성장의 배경에는 유전체 기술의 급속한 발전, 정밀의료에 대한 수요 증가, 임상 연구에서의 NGS 적용 확대, 유전성 질환의 유병률 증가 등이 있습니다. 기술 개선으로 더 빠르고 비용 효율적인 시퀀싱 플랫폼이 개발되어 NGS가 연구자와 임상의에게 더 쉽게 이용될 수 있게 되었습니다. 유전자 프로파일링에 기반한 맞춤형 치료 접근법에 대한 관심이 높아지고 진단 및 임상시험에 NGS가 통합되면서 헬스케어 및 생명과학 분야 전반에 걸쳐 NGS에 대한 수요가 더욱 증가하고 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
59억 7,000만 달러
시장 규모 : 2030년
205억 9,000만 달러
CAGR : 2025-2030년
22.92%
급성장 부문
데이터 분석
최대 시장
북미
시장 성장 촉진요인
맞춤형 의료에 대한 수요 증가
주요 시장 이슈
높은 비용 및 인프라 요구 사항
주요 시장 동향
NGS 데이터 분석에 인공지능 통합
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 차세대 시퀀싱 서비스 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
서비스별(인간 게놈 시퀀싱 서비스, 싱글 셀 시퀀싱 서비스, 미생물 게놈 기반 시퀀싱 서비스, 유전자 제어 서비스, 기타)
워크플로우별(프리시퀀스, 시퀀스, 데이터 분석)
최종사용자별(병원·클리닉, 학술·연구기관, 제약·바이오테크놀러지 기업, 기타)
지역별
기업별(2024)
제품 맵
서비스별
워크플로우별
최종사용자별
지역별
제6장 북미의 차세대 시퀀싱 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 차세대 시퀀싱 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 차세대 시퀀싱 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 차세대 시퀀싱 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 차세대 시퀀싱 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
최근 동향
합병과 인수
제품 출시
제13장 세계의 차세대 시퀀싱 서비스 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Quest Diagnostics Inc.
Applied Biological Materials, Inc.
Novogene Co, Ltd.
Azenta Life Sciences(GENEWIZ)
NanoString Technologies, Inc.
Illumina, Inc.
PacBio, Inc.
Gene by Gene Ltd
Lucigen Corporation
ARUP Laboratories
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Next Generation Sequencing (NGS) Services Market was valued at USD 5.97 billion in 2024 and is projected to reach USD 20.59 billion by 2030, growing at a CAGR of 22.92% during the forecast period. This growth is driven by rapid advancements in genomic technologies, rising demand for precision medicine, expanding applications of NGS in clinical research, and the increasing prevalence of genetic disorders. Technological improvements have led to faster and more cost-effective sequencing platforms, making NGS more accessible to researchers and clinicians. The growing focus on personalized treatment approaches based on genetic profiling and the integration of NGS in diagnostics and clinical trials are further boosting demand across healthcare and life science sectors.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 5.97 Billion
Market Size 2030
USD 20.59 Billion
CAGR 2025-2030
22.92%
Fastest Growing Segment
Data Analysis
Largest Market
North America
Key Market Drivers
Rising Demand for Personalized Medicine
The rising interest in personalized medicine is a major catalyst for the expansion of the NGS services market. Personalized medicine leverages genetic data to tailor medical care to individual patients, improving treatment effectiveness and disease management. NGS facilitates in-depth genomic analysis, helping identify mutations that influence disease risk and therapeutic responses.
Governments around the world are actively supporting this shift through large-scale initiatives. For instance, the U.S. National Institutes of Health's All of Us Research Program and the European Union's Horizon 2020 initiative have allocated substantial funding toward genomics research to promote personalized healthcare. These efforts underscore the central role of NGS in the evolving landscape of precision medicine.
Key Market Challenges
High Costs and Infrastructure Requirements
Despite the reduction in sequencing costs per genome, the overall financial burden of establishing and running NGS operations remains substantial. Setting up NGS laboratories demands significant investments in high-end equipment, computational systems, and trained personnel. Additionally, recurring costs for consumables, system maintenance, and data storage present ongoing challenges, particularly for facilities in developing nations.
The complexity of NGS workflows also requires continuous training and expertise, adding to operational overheads. These financial and technical barriers hinder the broader integration of NGS in low-resource settings. Although global programs-such as the Africa Pathogen Genomics Initiative-are working to expand infrastructure, disparities in access to NGS services persist.
Key Market Trends
Integration of Artificial Intelligence in NGS Data Analysis
The adoption of artificial intelligence (AI) and machine learning (ML) is emerging as a transformative trend in NGS services. Given the vast and complex nature of sequencing data, AI tools are increasingly essential for extracting meaningful insights. These technologies enhance pattern recognition, data interpretation, and predictive modeling in both clinical and research contexts.
In healthcare, AI-driven analysis supports accurate genetic diagnoses by identifying disease-associated variants and forecasting treatment responses. In research, AI facilitates discovery of novel biomarkers and therapeutic targets. Government-backed programs, such as those led by the U.S. NIH, are investing in AI-genomics integration, recognizing its potential to accelerate progress in personalized medicine and genomics-based research.
Key Market Players
Quest Diagnostics Inc.
Applied Biological Materials, Inc.
Novogene Co, Ltd.
Azenta Life Sciences (GENEWIZ)
NanoString Technologies, Inc.
Illumina, Inc.
PacBio, Inc.
Gene by Gene Ltd
Lucigen Corporation
ARUP Laboratories
Report Scope:
In this report, the Global Next Generation Sequencing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Next Generation Sequencing Services Market, By Service:
Human Genome Sequencing Services
Single Cell Sequencing Services
Microbial Genome-based Sequencing Services
Gene Regulation Services
Others
Next Generation Sequencing Services Market, By Workflow:
Pre-Sequencing
Sequencing
Data Analysis
Next Generation Sequencing Services Market, By End User:
Hospitals & Clinics
Academic & Research Institutions
Pharmaceutical & Biotechnology Companies
Others
Next Generation Sequencing Services Market, By Region:
North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing Services Market.
Available Customizations:
Global Next Generation Sequencing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Next Generation Sequencing Services Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Service (Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome-based Sequencing Services, Gene Regulation Services, Others)
5.2.2. By Workflow (Pre-Sequencing, Sequencing, Data Analysis)
5.2.3. By End User (Hospitals & Clinics, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Map
5.3.1. By Service
5.3.2. By Workflow
5.3.3. By End User
5.3.4. By Region
6. North America Next Generation Sequencing Services Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service
6.2.2. By Workflow
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Next Generation Sequencing Services Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Service
6.3.1.2.2. By Workflow
6.3.1.2.3. By End User
6.3.2. Canada Next Generation Sequencing Services Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Service
6.3.2.2.2. By Workflow
6.3.2.2.3. By End User
6.3.3. Mexico Next Generation Sequencing Services Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Service
6.3.3.2.2. By Workflow
6.3.3.2.3. By End User
7. Europe Next Generation Sequencing Services Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service
7.2.2. By Workflow
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Next Generation Sequencing Services Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Workflow
7.3.1.2.3. By End User
7.3.2. Germany Next Generation Sequencing Services Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Workflow
7.3.2.2.3. By End User
7.3.3. United Kingdom Next Generation Sequencing Services Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Service
7.3.3.2.2. By Workflow
7.3.3.2.3. By End User
7.3.4. Italy Next Generation Sequencing Services Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Service
7.3.4.2.2. By Workflow
7.3.4.2.3. By End User
7.3.5. Spain Next Generation Sequencing Services Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Service
7.3.5.2.2. By Workflow
7.3.5.2.3. By End User
8. Asia-Pacific Next Generation Sequencing Services Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service
8.2.2. By Workflow
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next Generation Sequencing Services Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Workflow
8.3.1.2.3. By End User
8.3.2. India Next Generation Sequencing Services Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Workflow
8.3.2.2.3. By End User
8.3.3. Japan Next Generation Sequencing Services Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Workflow
8.3.3.2.3. By End User
8.3.4. South Korea Next Generation Sequencing Services Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Workflow
8.3.4.2.3. By End User
8.3.5. Australia Next Generation Sequencing Services Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Service
8.3.5.2.2. By Workflow
8.3.5.2.3. By End User
9. South America Next Generation Sequencing Services Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service
9.2.2. By Workflow
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Next Generation Sequencing Services Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Workflow
9.3.1.2.3. By End User
9.3.2. Argentina Next Generation Sequencing Services Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Workflow
9.3.2.2.3. By End User
9.3.3. Colombia Next Generation Sequencing Services Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Workflow
9.3.3.2.3. By End User
10. Middle East and Africa Next Generation Sequencing Services Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service
10.2.2. By Workflow
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Next Generation Sequencing Services Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Workflow
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Next Generation Sequencing Services Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Service
10.3.2.2.2. By Workflow
10.3.2.2.3. By End User
10.3.3. UAE Next Generation Sequencing Services Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Service
10.3.3.2.2. By Workflow
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Next Generation Sequencing Services Market: SWOT Analysis